Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NYXH
NYXH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NYXH News
Nyxoah Secures FDA Approval and Successful U.S. Launch
Mar 20 2026
Yahoo Finance
Nyxoah (NYXH) Q4 2025 Earnings Call Transcript
Mar 20 2026
NASDAQ.COM
Nyxoah Reports Strong Q4 Earnings with 330.8% Revenue Growth
Mar 19 2026
seekingalpha
Nyxoah Receives Transparency Notification from Robert Taub
Feb 27 2026
Newsfilter
Nyxoah SA Discloses Voting Rights and Share Information
Feb 25 2026
Newsfilter
Nyxoah (NYXH) Projects 25% Revenue Growth for Q1 2026
Jan 14 2026
seekingalpha
Nyxoah Expects 348% Q4 Revenue Growth, $5.7M Forecast
Jan 13 2026
NASDAQ.COM
FibroBiologics (FBLG) Stock Rises 7.68%, Attracts Market Attention
Jan 13 2026
NASDAQ.COM
Nyxoah Receives 3.28% Shareholding Notification from BNP Paribas Asset Management
Jan 12 2026
Globenewswire
Nyxoah Receives 3.28% Shareholding Notification from BNP Paribas Asset Management
Jan 12 2026
Yahoo Finance
Nyxoah to Present Innovative OSA Treatment at 44th J.P. Morgan Healthcare Conference
Dec 29 2025
Globenewswire
Nyxoah Issues €22.5 Million First Tranche of Convertible Bonds
Dec 19 2025
Globenewswire
Nyxoah Issues €22.5 Million First Tranche of Convertible Bonds
Dec 19 2025
Newsfilter
Nyxoah Launches Genio in the Netherlands, Expanding Commercial Operations
Dec 17 2025
NASDAQ.COM
Nyxoah Launches Genio® Therapy in Netherlands with First Successful Implants
Dec 17 2025
Globenewswire
Nyxoah Launches Genio® Therapy in Netherlands with First Successful Implants
Dec 17 2025
Newsfilter
Show More News
